The "Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market" size was estimated at USD 2192.70 million in 2025 and is projected to reach USD 2738.38 million by 2032, exhibiting a CAGR of 2.50% during the forecast period.
The "North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market' size was estimated at USD 596.10 million in 2025, at a CAGR of 2.14% during the forecast period of 2025 through 2032.
Report Overview
Phosphodiesterase type 5 (PDE5) inhibitor is a class of medication that specifically targets and blocks the enzyme phosphodiesterase type 5. This enzyme is primarily found in the smooth muscle cells of the blood vessels, including those in the penis and lungs. By inhibiting PDE5, these medications promote the accumulation of cyclic guanosine monophosphate (cGMP), a chemical responsible for relaxing the smooth muscles and increasing blood flow in these areas. In the context of erectile dysfunction (ED), PDE5 inhibitors help improve blood flow to the penis, facilitating and maintaining erections. They are also used in the treatment of pulmonary arterial hypertension (PAH) to reduce blood vessel constriction and lower blood pressure in the lungs.
This report provides a deep insight into the global Phosphodiesterase Type 5 (PDE5) Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Phosphodiesterase Type 5 (PDE5) Inhibitor market in any manner.
Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Eli Lilly
- Pfizer
- Bayer
- BaiYunShan General Factory
- Teva Pharma
- SK Chemicals
- Seoul Pharma
- Jiangsu Yabang
- VIVUS
- Fujian Cosunter
- Youcare Pharmaceutical
By Type
- Sildenafil
- Tadalafil
- Avanafil
- Vardenafil
- Others
By Application
- Hospital
- Retail Pharmacy
- Online Pharmacies
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Phosphodiesterase Type 5 (PDE5) Inhibitor Market
- Overview of the regional outlook of the Phosphodiesterase Type 5 (PDE5) Inhibitor Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Phosphodiesterase Type 5 (PDE5) Inhibitor
1.2 Key Market Segments
1.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Segment by Type
1.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Overview
2.1 Global Market Overview
2.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Competitive Landscape
3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Manufacturers (2019-2025)
3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Manufacturers (2019-2025)
3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Sites, Area Served, Product Type
3.6 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Competitive Situation and Trends
3.6.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Rate
3.6.2 Global 5 and 10 Largest Phosphodiesterase Type 5 (PDE5) Inhibitor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Chain Analysis
4.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Phosphodiesterase Type 5 (PDE5) Inhibitor Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Type (2019-2025)
6.3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Market Share by Type (2019-2025)
6.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Price by Type (2019-2025)
7 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Sales by Application (2019-2025)
7.3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (M USD) by Application (2019-2025)
7.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Growth Rate by Application (2019-2025)
8 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Consumption by Region
8.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region
8.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region
8.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Region
8.2 North America
8.2.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Production by Region
9.1 Global Production of Phosphodiesterase Type 5 (PDE5) Inhibitor by Region (2019-2025)
9.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Region (2019-2025)
9.3 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Production
9.4.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Production Growth Rate (2019-2025)
9.4.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Production
9.5.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Production Growth Rate (2019-2025)
9.5.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Production (2019-2025)
9.6.1 Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Production Growth Rate (2019-2025)
9.6.2 Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Phosphodiesterase Type 5 (PDE5) Inhibitor Production (2019-2025)
9.7.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Production Growth Rate (2019-2025)
9.7.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Eli Lilly
10.1.1 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.1.2 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.1.4 Eli Lilly Business Overview
10.1.5 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor SWOT Analysis
10.1.6 Eli Lilly Recent Developments
10.2 Pfizer
10.2.1 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.2.2 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Bayer
10.3.1 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.3.2 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.3.4 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor SWOT Analysis
10.3.5 Bayer Business Overview
10.3.6 Bayer Recent Developments
10.4 BaiYunShan General Factory
10.4.1 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.4.2 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.4.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.4.4 BaiYunShan General Factory Business Overview
10.4.5 BaiYunShan General Factory Recent Developments
10.5 Teva Pharma
10.5.1 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.5.2 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.5.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.5.4 Teva Pharma Business Overview
10.5.5 Teva Pharma Recent Developments
10.6 SK Chemicals
10.6.1 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.6.2 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.6.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.6.4 SK Chemicals Business Overview
10.6.5 SK Chemicals Recent Developments
10.7 Seoul Pharma
10.7.1 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.7.2 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.7.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.7.4 Seoul Pharma Business Overview
10.7.5 Seoul Pharma Recent Developments
10.8 Jiangsu Yabang
10.8.1 Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.8.2 Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.8.3 Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.8.4 Jiangsu Yabang Business Overview
10.8.5 Jiangsu Yabang Recent Developments
10.9 VIVUS
10.9.1 VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.9.2 VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.9.3 VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.9.4 VIVUS Business Overview
10.9.5 VIVUS Recent Developments
10.10 Fujian Cosunter
10.10.1 Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.10.2 Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.10.3 Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.10.4 Fujian Cosunter Business Overview
10.10.5 Fujian Cosunter Recent Developments
10.11 Youcare Pharmaceutical
10.11.1 Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
10.11.2 Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
10.11.3 Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Product Market Performance
10.11.4 Youcare Pharmaceutical Business Overview
10.11.5 Youcare Pharmaceutical Recent Developments
11 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Region
11.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast
11.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Country
11.2.3 Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Region
11.2.4 South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Phosphodiesterase Type 5 (PDE5) Inhibitor by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Phosphodiesterase Type 5 (PDE5) Inhibitor by Type (2025-2032)
12.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Phosphodiesterase Type 5 (PDE5) Inhibitor by Type (2025-2032)
12.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast by Application (2025-2032)
12.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) Forecast by Application
12.2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Comparison by Region (M USD)
Table 5. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2022)
Table 10. Global Market Phosphodiesterase Type 5 (PDE5) Inhibitor Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Sites and Area Served
Table 12. Manufacturers Phosphodiesterase Type 5 (PDE5) Inhibitor Product Type
Table 13. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Phosphodiesterase Type 5 (PDE5) Inhibitor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
Table 22. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Type (K Units)
Table 23. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (M USD)
Table 24. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) by Type (2019-2025)
Table 25. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Type (2019-2025)
Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (M USD) by Type (2019-2025)
Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Share by Type (2019-2025)
Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Price (USD/Unit) by Type (2019-2025)
Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) by Application
Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Application (2019-2025) & (K Units)
Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Application (2019-2025)
Table 33. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Application (2019-2025) & (M USD)
Table 34. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2025)
Table 35. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Growth Rate by Application (2019-2025)
Table 36. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region (2019-2025) & (K Units)
Table 37. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Region (2019-2025)
Table 38. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Country (2019-2025) & (K Units)
Table 39. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region (2019-2025) & (K Units)
Table 41. South America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Sales by Region (2019-2025) & (K Units)
Table 43. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units) by Region (2019-2025)
Table 44. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Region (2019-2025)
Table 46. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 52. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 53. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Eli Lilly Business Overview
Table 55. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor SWOT Analysis
Table 56. Eli Lilly Recent Developments
Table 57. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 58. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 59. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Pfizer Business Overview
Table 61. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor SWOT Analysis
Table 62. Pfizer Recent Developments
Table 63. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 64. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 65. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor SWOT Analysis
Table 67. Bayer Business Overview
Table 68. Bayer Recent Developments
Table 69. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 70. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 71. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. BaiYunShan General Factory Business Overview
Table 73. BaiYunShan General Factory Recent Developments
Table 74. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 75. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 76. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Teva Pharma Business Overview
Table 78. Teva Pharma Recent Developments
Table 79. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 80. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 81. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. SK Chemicals Business Overview
Table 83. SK Chemicals Recent Developments
Table 84. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 85. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 86. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Seoul Pharma Business Overview
Table 88. Seoul Pharma Recent Developments
Table 89. Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 90. Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 91. Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Jiangsu Yabang Business Overview
Table 93. Jiangsu Yabang Recent Developments
Table 94. VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 95. VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 96. VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. VIVUS Business Overview
Table 98. VIVUS Recent Developments
Table 99. Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 100. Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 101. Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Fujian Cosunter Business Overview
Table 103. Fujian Cosunter Recent Developments
Table 104. Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Basic Information
Table 105. Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Product Overview
Table 106. Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Youcare Pharmaceutical Business Overview
Table 108. Youcare Pharmaceutical Recent Developments
Table 109. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Region (2025-2032) & (K Units)
Table 110. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Country (2025-2032) & (K Units)
Table 112. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Country (2025-2032) & (K Units)
Table 114. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Region (2025-2032) & (K Units)
Table 116. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Country (2025-2032) & (K Units)
Table 118. South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Type (2025-2032) & (K Units)
Table 122. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Price Forecast by Type (2025-2032) & (USD/Unit)
Table 124. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) Forecast by Application (2025-2032)
Table 125. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Phosphodiesterase Type 5 (PDE5) Inhibitor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (M USD), 2019-2032
Figure 5. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (M USD) (2019-2032)
Figure 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (M USD)
Figure 11. Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Share by Manufacturers in 2023
Figure 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Manufacturers in 2023
Figure 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Phosphodiesterase Type 5 (PDE5) Inhibitor Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type
Figure 18. Sales Market Share of Phosphodiesterase Type 5 (PDE5) Inhibitor by Type (2019-2025)
Figure 19. Sales Market Share of Phosphodiesterase Type 5 (PDE5) Inhibitor by Type in 2023
Figure 20. Market Size Share of Phosphodiesterase Type 5 (PDE5) Inhibitor by Type (2019-2025)
Figure 21. Market Size Market Share of Phosphodiesterase Type 5 (PDE5) Inhibitor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application
Figure 24. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Application (2019-2025)
Figure 25. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Application in 2023
Figure 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2025)
Figure 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application in 2023
Figure 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Growth Rate by Application (2019-2025)
Figure 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Region (2019-2025)
Figure 30. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Country in 2023
Figure 32. U.S. Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Country in 2023
Figure 37. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Region in 2023
Figure 44. China Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (K Units)
Figure 50. South America Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Country in 2023
Figure 51. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Production Market Share by Region (2019-2025)
Figure 62. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 65. China Phosphodiesterase Type 5 (PDE5) Inhibitor Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share Forecast by Type (2025-2032)
Figure 70. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Forecast by Application (2025-2032)
Figure 71. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share Forecast by Application (2025-2032)
